AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.

Cao W, Li J, Hao Q, Vadgama JV, Wu Y. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Breast Cancer Res. 2019 02 21; 21(1):29.

View in: PubMed

subject areas

AMP-Activated Protein Kinases
Antineoplastic Agents
Cell Line, Tumor
Enzyme Activators
Female
Humans
Metabolic Networks and Pathways
MicroRNAs
Protein Kinase Inhibitors
Signal Transduction

authors with profiles

Jaydutt V Vadgama, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support